Krawczyk, A., Strzałka-Mrozik, B., Juszczyk, K., Kimsa-Dudek, M., Wcisło-Dziadecka, D., & Gola, J. (2023). The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis. Current pharmaceutical biotechnology, 24(2), 330. https://doi.org/10.2174/1389201023666220628111644
Citace podle Chicago (17th ed.)Krawczyk, Agata, Barbara Strzałka-Mrozik, Karol Juszczyk, Magdalena Kimsa-Dudek, Dominika Wcisło-Dziadecka, a Joanna Gola. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology 24, no. 2 (2023): 330. https://doi.org/10.2174/1389201023666220628111644.
Citace podle MLA (9th ed.)Krawczyk, Agata, et al. "The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis." Current Pharmaceutical Biotechnology, vol. 24, no. 2, 2023, p. 330, https://doi.org/10.2174/1389201023666220628111644.